Transforming growth factor-β1 gene polymorphisms and bone turnover, bone mineral density and fracture risk in southern Chinese women

Calcified Tissue International

Volumn 74, Issue 6, 2004, Pages 516-521

  Lau, H H L ^a   Ho, A Y Y ^a   Luk, K D K ^a   Kung, A W C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bone turnover; Southern Chinese women; TGF 1

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; OSTEOCALCIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CHINESE; FEMALE; FEMUR; FRACTURE; FRAGILITY FRACTURE; GENETIC POLYMORPHISM; GENOTYPE; HIP; HUMAN; NORMAL HUMAN; OSSIFICATION; OSTEOLYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPINE FRACTURE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE REMODELING; FEMALE; FRACTURES, BONE; HONG KONG; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 2942683420     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-004-0163-4     Document Type: Article

References (38)

1. Kanis JA, Melton III LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137-1141
2. Pock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S (1987) Genetic determinants of bone mass in adults: a twin study. J Clin Invest 80:706-710
3. Gueguen R, Jouanny P, Guillemin F, Kuntz C, Poure J, Siest G (1995) Segregation analysis and variance components analysis on bone mineral density in healthy families. J Bone Miner Res 12:2017-2022
4. Ferrari S, Rizzoli R, Chevalley T, Slosman D, Eisman JA, Bonjour JP (1995) Vitamin D-receptor-gene polymorphisms and change in lumbar spine bone mineral density. Lancet 345:423-424
5. Kung AWC, Yeung SCC, Lau KS (1998) Vitamin D receptor gene polymorphisms and peak bone mass in southern Chinese women. Bone 22:389-393
6. Grant SFA, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH (1996) Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type Iα1 gene. Nature Genetics 14:203-205
7. Langdahl BL, Lokke E, Caaarsten M, Stenkjaer LL, Eriksen EFA (2000) TA repeat polymorphism in the estrogen receptor gene is associated with osteoporotic fractures but polymorphisms in the first exon and intron are not. J Bone Miner Res 15:2222-2230
8. Ho AYY, Yeung SSC, Kung AWC (2000) PvuII polymorphisms of the estrogen receptor α and bone mineral density in healthy southern Chinese women. Calcif Tissue Int 66:405-408
9. Lau HH, Ho AYY, Luk KDK, Kung AWC (2002) Estrogen receptor β gene polymorphisms are associated with higher bone mineral density in premenopausal, but not postmenopausal, southern Chinese women. Bone 31:276-281
10. Murray RE, McGuigan F, Grant SF, Reid DM, Ralston SH (1997) Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone 21:89-92
11. Masi L, Becheini L, Gennari L, Colli E, Mansani R, Falchetti A, Cepollaro C, Gonnelli S, Tanini A, Brandi ML (1998) Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women. Biochem Biophys Res Commun 2452:622-626
12. Langdahl BL, Carstens M, Atenkjaer L, Eriksen EF (2002) Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. J Bone Miner Res 16:1245-1255
13. Pfeilschifter J, D'Souza SM, Mundy GR (1987) Effects of transforming growth factor beta-β on osteoblastic osteosarcoma cells. Endocrinology 121:212-218
14. Chenu C, Pfeilschifter J, Mundy GR, Roodman GD (1988) Transforming growth factor beta β inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci USA 85:5683-5687
15. Bonewald LF, Mundy GR (1990) Role of transforming growth factor-beta in bone remodeling. Clin Orthop 250:261-276
16. Pacifici R (1991) Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043-1051
17. Oursler MJ, Cortese C, Keeting P, Anderson MA, Bonde SK, Riggs BL, Spelsberg TC (1991) Modulation of transforming growth factor-β production in normal human osteoblast-like cells by 17β-estradiol and parathyroid hormone. Endocrinology 129:3313-3320
18. Mundy GR, Bonewald LF (1992) Transforming growth factor beta. In: Gowen M (ed) Cytokines and bone metabolism. CRC, Boca Raton, FL, pp 93-107
19. Janssens K, Gershoni-Baruch R, Guanabens N, et al. (2000) Mutations in the gene encoding the latency-associated peptide of TGF-beta 1 cause Camurati-Engelmann disease. Nat Genet 26:273-275
20. Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, Hase M, Takai H, Harada A, Ikeda K (1998) Association of a polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 13:1569-1575
21. Yamada Y, Miyauchi A, Takaka M, Mizuno M, Harada A (2001) Association of the C-509 → T polymorphism, alone or in combination with the T869 → C polymorphism, of the transforming growth factor-β1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women. J Mol Med 79:149-156
22. Langdhl BL, Knudsen JY, Jensen HK, Gregersen N, Eriksen EF (1997) A sequence variation: 713-8delc in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass and increased bone turnover in both osteoporotic and normal women. Bone 203:289-294
23. Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF (2003) Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis. Bone 32:297-310
24. Keen RW, Snieder H, Molloy H, et al. (2001) Evidence of association and linkage disequilibrium between a noval polymorphism in the transforming growth factor β1 gene and hip bone mineral density: a study of female twins. Rheumatology 40:48-54
25. Yamada Y, Harada A, Hosoi T, Miyauchi A, Ikeda K, Ohta H, Shiraki M (2000) Association of transforming growth factor β1 genotype with therapeutic response to active vitamin D for postmenopausal osteoporosis. J Bone Miner Res 15:415-420
26. Bertoldo F, D'Agruma L, Furlan F, Colapietro F, Lorenzi MT, Maioran N, Iolascon A, Zelante L, LoCascio V, Gasparini P (2000) Transforming growth factor-beta 1 gene polymorphism, bone turnover, and bone mass in Italian postmenopausal women. J Bone Miner Res 15:634-639
27. Thompson EA, Deeb S, Walker D, Motulsky AG (1988) The direction of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am J Hum Genet 42:113-124
28. Kung A (1996) The prevalence and risk factors of fractures in Hong Kong. In: Lam SK (ed) The Health of the elderly in Hong Kong. Hong Kong University Press, Hong Kong, pp 161-172
29. 29 → C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF beta1 in a population-based sample of postmenopausal German women. Calcif Tissue Int 69:315-320
30. Ziv E, Cauley J, Morin P, Saiz R, Browner W (2003) No association between the TGF-β1 Leu10Pro polymorphism and osteoporosis among white women in United Sates. Am J Med 114:227-231
31. Yamada Y, Ando F, Nilno N, Shimokata H (2003) Association of polymorphisms of interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men. J Clin Endocrinol Metab 88:3372-3378
32. Garnero P, Sornay-Rendu E, Doboeuf F, Delmas PD (1999) Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. J Bone Miner Res 14:1614-1621
33. Rosen CJ, Chesnurt CH III, Mallinak NJS (1997) The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement with calcium supplementation. J Clin Endocrinol Metab 82:1904-1910
34. Riis BJ, Hansen MA, Jensen AM, Overgaard K, Christiansen C (1996) Low bone mass and fast rate of bone loss at menopause: equal risk factors for facture: A 15-year follow-up study. Bone 19:9-12
35. Eastell R, Barton I, Hannon RA, Chines A, Garnero P, Delmas PD (2003) Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res 18:1051-1056
36. Stunnenberg HG (1993) Mechanisms of transactivation by retinoic acid receptors. Bioassays 15:309-315
37. Grainger DJ, Witchell CM, Metcalfe JC (1995) Tamoxifen elevates transforming growth factor-beta and suppresses diet-induced formation of lipid lesions in mouse aorta. Nat Med 1:1067-1073
38. Grainger DJ, Heathcote K, Chiano MN (1999) Genetic control of the circulating concentration of transforming growth factor type β. Hum Mol Genet 1:93-97